Sleep Management for Sleep Deprivation
Trial Summary
What is the purpose of this trial?
To further understand the impact of acute sleep deprivation and recovery sleep on the processing of emotional information the investigators will address and attempt to answer three questions, (i) how both undisturbed sleep and sleep deprivation affect the processing and retrieval of emotional information, (ii) what neural and psychophysiological mechanisms are associated with these behavioral effects, and (iii) to explore the ability of recovery sleep to reverse the effects of sleep deprivation. Together, these studies will provide a greater breadth and depth of knowledge concerning sleep's role in emotion processing and regulation. Given the growing societal tendency to view sleep as unproductive-foregoing it to lengthen work days and increase social opportunities- such knowledge would be of practical importance for understanding the role of sleep in healthy emotional functioning, particular for individuals experiencing periods of increased stress and emotional distress (e.g., new parents, hospital staff, or combat troops).
Will I have to stop taking my current medications?
Yes, you will need to stop taking any drugs that could affect sleep or cognitive functioning, such as sleeping pills or antidepressants, to participate in this trial.
What data supports the effectiveness of the treatment for Sleep Management for Sleep Deprivation?
Research suggests that improving sleep quality through non-drug methods, like clustering care at night, can help patients recover better from sleep deprivation. Although studies on these interventions often have mixed results, they are recommended as a first-choice treatment to enhance sleep and overall recovery.12345
Is sleep management for sleep deprivation generally safe for humans?
How is the treatment of sleep deprivation unique compared to other treatments?
The treatment of sleep deprivation, also known as sleep loss or insufficient sleep, is unique because it involves therapeutic sleep deprivation or induced-wakefulness therapy, which has been shown to have antidepressive effects. Unlike other treatments that focus on improving sleep quality or duration, this approach uses controlled sleep deprivation as a therapeutic tool, particularly for depressive disorders.410111213
Research Team
Tony Cunningham, PhD
Principal Investigator
Beth Israel Deaconess Medical Center
Eligibility Criteria
This trial is for individuals who can follow the study's rules and are willing to avoid alcohol and recreational drugs during the study. They must have normal vision (with or without correction) and be right-handed. People with sleep issues, mental illness, neurological disorders, or those taking medication affecting sleep or cognition cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Sleep Deprivation
Participants undergo sleep deprivation before participating in training and testing sessions
Daytime Nap
Participants are given a 2-hour nap opportunity to quantify its restorative effects
Overnight Sleep
Participants are permitted a night of polysomnograph-recorded sleep before participating in training and testing sessions
Follow-up
Participants are monitored for changes in emotional memory and affective reactivity after interventions
Treatment Details
Interventions
- Daytime nap
- Sleep Deprivation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Beth Israel Deaconess Medical Center
Lead Sponsor
Boston College
Collaborator